Conference Coverage

Dr. Eve Espey: Some good news in her 2019 contraceptive update


 

EXPERT ANALYSIS FROM ACOG 2019

Additional future directions

One technology in development is a longer-acting injectable, such as a 6- or 9-month Depot-type shot.

Biodegradable implants also are in development. “What a cool idea – it just disappears in your arm, no need to remove it,” Dr. Espey said, adding that nonsurgical permanent sterilization is another possible advance, which would be “a holy grail.”

As for male contraception?

“I’ve been saying for about 25 years that in 5 years we’ll have a male contraceptive, so I’m not going to say it anymore with any kind of time frame, but it’s possible,” she said.

Dr. Espey reported having no financial disclosures.

Pages

Recommended Reading

Courts temporarily block Title X changes
MDedge ObGyn
Liletta IUD efficacy extends to 6 years
MDedge ObGyn
2019 Update: Contraceptives and unintended pregnancy rates
MDedge ObGyn
Immediate postpartum LARC: ‘Agony and ecstasy’
MDedge ObGyn
Addressing the sexual and reproductive health needs of trans and gender nonconforming patients
MDedge ObGyn
Pharmacist-prescribed hormonal contraception safe, effective
MDedge ObGyn
Postpartum LARC uptake increased with separate payment
MDedge ObGyn
Judge bars contraceptive mandate from being enforced
MDedge ObGyn
Ovarian reserve markers fall on isotretinoin, but rebound after stopping treatment
MDedge ObGyn
LARC prolongs interpregnancy intervals but doesn’t cut preterm birth risk
MDedge ObGyn